Physician profile
Scot Bradley Glasberg
NPI 1811955602
$959,440.46
in general payments reported to CMS, 2019-2025
15 companies · $69K in 2025
The $69K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225K · 2020: $143K · 2021: $191K · 2022: $129K · 2023: $118K · 2024: $84K · 2025: $69K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $208K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $46K · Travel and Lodging: $11K · Food and Beverage: $5,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $208,141.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $45,812.50 |
| Travel and Lodging | $11,289.05 |
| Food and Beverage | $5,175.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $648,535.95 | 2019-2022 | |
| Abbvie INC. | $222,649.49 | 2023-2025 | |
| Kci USA, INC. | $57,130.75 | 2021-2023 | Prevena, Prevena Restor Bellaform, V.A.C. Veraflo |
| Solventum Corporation | $27,876.44 | 2025 | Prevena, V.A.C. Veraflo, V.A.C.Ulta |
| Vertex Pharmaceuticals Incorporated | $1,143.15 | 2025 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $825.99 | 2021 | |
| Stryker Corporation | $428.92 | 2021-2023 | Stryker |
| Tela Bio, INC. | $184.58 | 2022 | |
| Mentor Worldwide LLC | $164.17 | 2022-2024 | Mentor Siltex Round Spectrum |
| Axogen | $153.84 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Polynovo North America LLC | $148.15 | 2025 | Novosorb Btm |
| Davol INC. | $97.46 | 2025 | Phasix Mesh |
| Integra Lifesciences Corporation | $35.97 | 2025 | Integra, Omnigraft, Surgimend |
| Medtronic, INC. | $35.00 | 2022 | |
| Ethicon US, LLC | $30.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scot Glasberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.